Fibrosis_SCIEPublish

Fibrosis is a peer-reviewed and open access journal publishing manuscripts on novel and established Fibrosis community. By SCIEPublish.

[Fibrosis_SCIEPublish @Fibrosis_htu]

🧬 New Review:

This review highlights the potential of organoid models in unraveling genetic and epigenetic mechanisms of liver fibrosis and advancing biomarker discovery and therapeutic development.

Read more:
https://t.co/yCQsPFDXce

#Fibrosis #LiverFibrosis #Organoids

[Fibrosis_SCIEPublish @Fibrosis_htu]

Mitochondrial FAO dysfunction in tubulointerstitial fibrosis: mechanisms & therapeutic advances.📑 New Publication | Fibrosis
Full text: https://t.co/AhASItLAad
#Nephrology #KidneyResearch

[Giada Sebastiani @GiadaSebastiani]

🚨Pleased to share our new publication in "Journal of Viral Hepatitis"🚨
✳️#MASLD associated with significant liver fibrosis in 590 patients with #HCV
✳️Hierarchical association seen with #diabetes, #hypertension and #overweight phenotypes of MASLD

👉https://t.co/r3qPwDwzhp

[Naftali Kaminski @KaminskiMed]

Is this letter published on ERJ open this week, the most important Pulmonary Fibrosis paper of 2025? “Neutrophils in idiopathic pulmonary fibrosis patients are phenotypically distinct from controls”
Kudos Drs Chong, Porter & team
#HappyNewYear2026
https://t.co/31IjtgWfDz

[Dr. Hardik Patel 🩺💉 @hardik4u24]

#Aging 🧓🏽 + CKD 🫘 = a vicious loop

🛡️Immunosenescence → ↓ defense & ↑ chronic inflammation
🧪CKD → uremic toxins, oxidative stress

➡️ Renal senescence, nephron loss & fibrosis accelerate

Break the inflammation–senescence axis

🔗 https://t.co/ODqfHyP4Jt

#CKD #Nephrology

[nervemed @nervemed]

Cystic Fibrosis

[Biomedical Picture of the Day BPoD @BPoD_s]

Human liver tissue with & without fibrosis reconstructed at cell level in 3D - insights for understanding liver disease & how to treat it

📹 Wesley B. Fabyan & Chelsea L. Fortin et al @kellystevenslab @UW in @ScienceAdvances
➡️ https://t.co/y5xJll9BwM

[Fibrosis_SCIEPublish @Fibrosis_htu]

🎉New Special Issue "Advances in Genetic/Epigenetic Mechanisms and Biomarker Discovery of Liver Fibrosis" is open for submissions!

🗓️Submission deadline: 31 December 2026.

➡️For more details, please visit:
https://t.co/rYQWNeneHB

#OpenAccess #Fibrosis

[ATS AII @ATS_AII]

Strong work by Michael Lu describing phenotypes of resting and exertional hypoxemia in COPD. Three distinct patterns of hypoxemia were identified with some unique clinical measures and outcomes.
#COPD #ATS #AII #oxygen

[Eric Topol @EricTopol]

Confirming the pivotal role of blocking inflammation for lifespan and healthspan expansion
Role of interleukin-11 knockout or inhibition
https://t.co/gYcTN9SAcX
@Nature @justsaysinmice @stuartacook1 @dukenus

[Fibrosis_SCIEPublish @Fibrosis_htu]

The Double Face of Exosomes: Drivers of lung fibrosis or a promising new therapy? A new review explores their dual role. 🫁

👉 https://t.co/7CC4VZPIux

#Exosomes #IPF #LungFibrosis #MSC #StemCells

[Fibrosis_SCIEPublish @Fibrosis_htu]

#Modafinil for scars? New study shows it inhibits adenosine deaminase to suppress hypertrophic scar formation. A novel anti-fibrotic mechanism! #Science #MedTwitter 🔗

https://t.co/5PGO2vOo9r

[Fibrosis_SCIEPublish @Fibrosis_htu]

New review spotlights non-invasive fibrosis assessment: Ultrasound elastography, fMRI, FAPI-PET/CT, & nanotech—replacing risky renal biopsy for elders!
Read: https://t.co/bC9gDfdZ5Y
#RenalFibrosis #AgingKidney #NonInvasiveDiagnostics #MedicalResearch

[Fibrosis_SCIEPublish @Fibrosis_htu]

Fibrosis breakthrough! 🧬 GLP-1/GIP agonists hold anti-fibrotic promise for chronic inflammatory disorders. Full review: https://t.co/z7DbKV4knu
#Fibrosis #GLP1 #AntiFibroticTherapeutics #ChronicInflammation #MedicalResearchRead

[Fibrosis_SCIEPublish @Fibrosis_htu]

⚡Today's paper recommendation:

How #nanotechnology is tackling #CysticFibrosis. Explores mucus penetration, gene delivery & more. Essential for #drugdelivery research.

Read: https://t.co/CX8oRPcnzR

#Science #Medicine #fibrosis

[Fibrosis_SCIEPublish @Fibrosis_htu]

📢Call for papers Special Issue "Fibrosis Research in Systemic Sclerosis" is open for submissions! 📷Submission deadline: 31 March 2026 📷 https://t.co/1CfKbs2sjT
#OpenAccess #SystemicSclerosis #Fibrosis

[medRxiv @medrxivpreprint]

Genome-wide analysis of tandem repeat variation identifies SLC15A4 as a susceptibility gene for idiopathic pulmonary fibrosis https://t.co/PgSJWsPPiy #medRxiv

[Colin Edwards @ColinEdwards767]

Delighted with the opportunity to present on behalf of @ILFA_Ireland at @irishthoracicS conference 2025. Prescriptions & costs of #antifibrotics for treatment of #interstitial lung disease are increasing. Great feedback at the discussion session.

[Fibrosis_SCIEPublish @Fibrosis_htu]

✨New paper published✨
Immunoprofiling of Alcohol-Activated Hepatic Stellate Cells Reveals Mechanisms of Immune Evasion through NK/T Lymphocyte Checkpoint Signaling
🔓Read full paper for free: https://t.co/ttxesEKAuF
#HepaticStellateCells

[Fibrosis_SCIEPublish @Fibrosis_htu]

🧪Don't miss this interesting #Article
Identification of Pathways That Drive Myofibroblast Transformation in Hypertrophic Scars
🔗Read full article for free:https://t.co/HKR51HTO4Q
#Myofibroblast